NRX Pharmaceuticals Balance Sheet
NRX Pharmaceuticals's total assets for Q4 2025 were $12.96M, a decrease of -13.60% from the previous quarter. NRXP total liabilities were $28.89M for the fiscal quarter, a -29.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.